The roles of dopamine oxidative stress and dopamine receptor signaling in aging and age-related neurodegeneration

Antioxidants and Redox Signaling

Volumn 2, Issue 3, 2000, Pages 449-460

  Luo, Y ^a   Roth, G S ^a  

^a NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOPAMINE;

AGING; AMNESIA; DOPAMINERGIC SYSTEM; LEARNING DISORDER; LOCOMOTION; NERVE DEGENERATION; OXIDATIVE STRESS; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033759168     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/15230860050192224     Document Type: Review

References (88)

1. Oxygen free radicals and Parkinson's disease
2. Effects of hypoxia on the activity of the dopaminergic neuron system in the rat striatum as studied by in vivo brain microdialysis
3. Apoptosis and autophagy in nigral neurons of patients with Parkinson's disease
4. Age-related defects in spatial memory are correlated with defects in the late phase of hippocampal long-term potentiation in vitro and are attenuated by drugs that enhance the cAMP signaling pathway
5. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors
6. Evidence for dopamine D2 receptor mRNA expression by striatal astrocytes in culture: In situ hybridization and polymerase chain reaction studies
7. Differentiated rat glial cell strain in tissue culture
8. Involvement of hippocampal cAMP/cAMP-dependent protein kinase signaling pathways in a late memory consolidation phase of aversively motivated learning in rats
9. Mechanisms of action of a dominant-negative mutant of c-Jun
10. Striatal protection induced by lesioning the substantia nigra of rats subjected to focal ischemia
11. Abnormal synaptic plasticity in the striatum of mice lacking dopamine D2 receptors
12. Differential neurotoxicity induced by L-DOPA and dopamine in cultured striatal neurons
13. The generation of hydrogen peroxide, superoxide radical, an hydroxyl radical by 6-hydroxydopamine, dialuric acid, and related cytotoxic agents
14. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1
15. The effect of aging on the D1 dopamine receptors in human frontal cortex
16. JNK1: A protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain
17. Independent MAP kinase signal transduction pathways defined by MEK and MKK isoforms
18. Age-related declines in nigral neuronal function correlate with motor impairments in rhesus monkeys
19. Aging and Parkinson's disease: Substantia nigra regional selectivity
20. Pre- and post-synaptic neurotoxic effects of dopamine demonstrated by intrastriatal injection
21. Dopaminergic modulation of excitotoxicity in rat striatum: Evidence from nigrostriatal lesions
22. The apparent autoxidation rate of catechols in dopamine-rich regions of human brains increases with the degree of depigmentation of substantia nigra
23. In vivo autoxidation of dopamine in guinea pig striatum increases with age
24. Selective role of glutathione in protecting human neuronal cells from dopamine-induced apoptosis
25. Substantia nigra lesions protects against ischemic damage in the striatum
26. Age-related changes in dopaminergic and serotonergic indices in the rat forebrain
27. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones
28. A c-Jun dominant negative mutant protects sympathetic neurons against programmed cell death
29. 2-receptor-containing neurons in the rat striatum
30. Enzymatic oxidation of dopamine: The role of prostaglandin H synthase
31. Role of oxidation in the neurotoxic effects of intrastriatal dopamine injections
32. Intrastriatal injection of dopamine results in DNA damage and apoptosis in rats
33. Dopamine D1 receptor ligands modulate cognitive performance and hippocampal acetylcholine release in memory-impaired aged rats
34. Characterization of jun D: A new member of the jun proto-oncogene family
35. Iron and aluminum increase in the substantia nigra of patients with Parkinson's disease: An x-ray microanalysis
36. Binding sites for [3H]dopamine and dopamine-antagonists on cultured astrocytes of rat striatum and spinal cord: An autoradiographic study
37. Action of dopamine and serotonin on the membrane potential of cultured astrocytes
38. Suppression of c-Jun/AP-1 activation by an inhibitor of tumor promotion in mouse fibroblast cells
39. Nuclear translocation of NF-kappaB is increased in dopaminergic neurons of patients with parkinson disease
40. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways
41. Iron-melanin complex in substantia nigra of parkinsonian brains: An x-ray microanalysis
42. Altered mitochondrial function, iron metabolism and glutathione levels in Parkinson's disease
43. The stress-activated protein kinase sub-family of c-Jun kinases
44. Cultured rat striatal and cortical astrocytes protect mesencephalic dopaminergic neurons against hydrogen peroxide toxicity independent of their effect on neuronal development
45. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis
46. Is binding to nicotinic acetylcholine and dopamine receptors related to working memory in rats?
47. Inhibition of nuclear translocation of transcription factor NF-κB by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence
48. 2-terminal kinases
49. Spatial memory deficits in aged rats: Contributions of monoaminergic systems
50. Intrastriatal dopamine injection induces apoptosis through oxidation-involved activation of transcription factors AP-1 and NF-κB in rats
51. Dopamine stimulates redox-tyrosine kinase signaling and p38 MAPK in activation of astrocytic C6-D2L cells
52. D2 dopamine receptors stimulate mitogenesis through PTX-sensitive G proteins and Ras involved ERK and SAP/JNK pathways in rat C6-D2L glioma cells
53. Dopamine induces apoptosis through an oxidation-involved SAPK/JNK activation pathway
54. Life-long dietary restriction attenuates age-related increases in hippocampal glial fibrillary acidic protein mRNA
55. Absence of opiate rewarding effects in mice lacking dopamine D2 receptors
56. Dopamine induces apoptotic cell death of a catecholaminergic cell line derived from the central nervous system
57. Loss of autoreceptor function in dopaminergic neurons from dopamine D2 receptor deficient mice
58. Toxicity of 6-hydroxydopamine and dopamine for dopaminergic neurons in culture
59. Apoptosis in neurodegenerative disorders
60. Age-related motor slowness: Simply strategic?
61. Functional characterization of a rat dopamine D-2 receptor cDNA expressed in a mammalian cell line
62. Increased abundance of alternatively spliced forms of D2 dopamine receptor mRNA after denervation
63. Motor function in the normal aging population: Treatment with levo-dopa
64. Dopamine D2 receptor agonists protect against ischaemia-induced hippocampal neurodegeneration in global cerebral ischerrda
65. Dopamine-induced programmed cell death in mouse thymocytes
66. Metals and free radicals in neurodegeneration
67. Dopamine D2 receptors in signal transduction and behavior
68. Nuclear factor-κB contributes to excitotoxin-induced apoptosis in rat striatum
69. Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine
70. Cellular and molecular mechanisms of impaired dopaminergic functions during aging
71. Regulation of fast inactivation of cloned mammalian IK(A) channels by cysteine oxidation
72. Reduction of cortical dopamine, noradrenaline, serotonin and their metabolises in Parkinson's disease
73. Role of dopamine in the neurotoxic effects of methamphetamine
74. Dopamine induces apoptosis in cultured rat striatal neurons: Possible mechanism of D2-dopamine receptor neuron loss during aging
75. Dopamine-induced apoptosis in human neuronal cells: Inhibition by nucleic acids antisense to the dopamine transporter
76. Dopaminergic A10 neurons are involved in cognitive functions
77. Activation of transcription factor NF-κB is suppressed by curcurmin (diferulolylmethane)
78. Increase in extracellular dopamine in the striatum during cerebral ischemia: A study utilizing cerebral microdialysis
79. 3H]rolipram binding in the rat brain
80. Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis
81. Neurotoxin-induced cell death in neuronal PC12 cells is mediated by induction of apoptosis
82. Sensitization of endogenous and recombinant adenylate cyclase by activation of D2 dopamine receptors
83. Astrocyte heterogeneity
84. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
85. Identification of neuronal programmed cell death in situ in the striatum of normal adult rat brain and its relationship to neuronal death during aging
86. Monoamine-induced apoptotic neuronal cell death
87. Dopamine induces apoptosis-like cell death in cultured chick sympathetic neurons - A possible novel pathogenetic mechanism in Parkinson's disease
88. Short- and long-term changes in striatal neurons and astroglia after transient forebrain ischemia in rats